My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Emergent BioSolutions Inc. Common Stock (NY:EBS)

10.83 -0.02 (-0.18%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

PureCycle Technologies, Canadian Solar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 22, 2023

U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript ↗

August 09, 2023

EBS earnings call for the period ending June 30, 2023.

Via The Motley Fool

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 01, 2023

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

Via Benzinga

Why Emergent BioSolutions Stock Dived by 9% Today ↗

June 27, 2023

Investors didn't greet news of the CEO's departure warmly.

Via The Motley Fool

Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday ↗

August 01, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 31, 2023

Via Benzinga

Why Emergent Biosolutions Stock Is Surging After The Close ↗

July 31, 2023

Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher in Monday's after-hours session after the company was awarded a 10-year contract for

Via Benzinga

Potential Delay In iPhone 15 Debut Could Impact Apple's Margins, Meta's Threads App Faces User Exodus, Microsoft CEO Satya Nadella's Earnings Exceed $1B: Today's Top Stories ↗

July 21, 2023

New York Times

Via Benzinga

Is Emergent BioSolutions Stock a Buy Now? ↗

June 09, 2023

The deluge of bad news seems to be over, and a recovery could be in the works.

Via The Motley Fool

Down 75%, Can Emergent BioSolutions Turn Things Around? ↗

June 07, 2023

Has the stock finally bottomed out?

Via The Motley Fool

Stocks That Hit 52-Week Lows On Friday ↗

July 28, 2023

Friday's session saw 59 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 21, 2023

Via Benzinga

Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket ↗

July 21, 2023

Gainers BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital...

Via Benzinga

What 4 Analyst Ratings Have To Say About Emergent BioSolutions ↗

May 31, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 21, 2023

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Emergent BioSolutions' Two-Dose Anthrax Vaccine Secures FDA Nod; Shares Jump ↗

July 21, 2023

The FDA approved Emergent BioSolutions Inc's (NYSE: EBS) anthrax vaccine for adults

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 05, 2023

Wednesday's session saw 43 companies set new 52-week lows.

Via Benzinga

Recap: Emergent BioSolutions Q1 Earnings ↗

May 09, 2023

Via Benzinga

Better Recovery-Story Buy: Emergent BioSolutions or Invitae? ↗

June 26, 2023

Both of these stocks have plummeted more than 50% over the past year.

Via The Motley Fool

Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data ↗

June 20, 2023

Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in

Via Benzinga

Nasal-Spray Millionaire: Indivior's Opvee Nasal Spray Gets FDA Green Light for Opioid Overdose Treatment ↗

May 23, 2023

The FDA has approved Indivior PLC's (OTC: INVVY) Opvee (nalmefene) nasal spray for the emergency treatment of opioid overdose in adults and pediatric patients aged 12 years and older.

Via Benzinga

Why Emergent BioSolutions Stock Inched Slightly Higher Today ↗

May 15, 2023

Investors approved, if not enthusiastically, their company's latest asset sale.

Via The Motley Fool

Emergent BioSolutions (EBS) Q1 2023 Earnings Call Transcript ↗

May 10, 2023

EBS earnings call for the period ending March 31, 2023.

Via The Motley Fool

Emergent Plans $50 Price Point For Narcan OTC Version For Opioid Overdose Reversal ↗

April 21, 2023

Emergent BioSolutions Inc (NYSE: EBS) looks to price its over-the-counter (OTC) version of its opioid overdose reversal Narcan at around $50 per carton of two 4 mg doses.

Via Benzinga

Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 12, 2023

Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...

Via Benzinga

CPI Sent Market Surging - But Some Stocks Took A Hit: Spotlight On Top Gainers And Hard-Hit Decliners ↗

April 12, 2023

The market is trading higher on Wednesday after the Labor Department reported the latest Consumer Price Index figure for the month of March. While most stocks are trading higher alongside the major...

Via Benzinga

Tesla, Apple, Riot Platforms, AMC, Emergent Biosolutions: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

April 10, 2023

U.S.

Via Benzinga

Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move ↗

April 10, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023 ↗

April 10, 2023

Via Benzinga

Micron Technology, Greenbrier Companies And Other Big Stocks Moving Higher On Monday ↗

April 10, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling over 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.